MetLife Investment Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-109,657	Closed	-$827K	–	2938
2023 Q1	$827K	Hold	109,657	–	–	0.01%	1332
2022 Q4	$1.11M	Sell	109,657 -3,084	-3%	-$31.2K	0.01%	1173
2022 Q3	$1.12M	Buy	112,741 +3,554	+3%	+$35.1K	0.01%	1129
2022 Q2	$1.16M	Buy	+109,187	New	+$1.16M	0.01%	1134